1.
The aim of this collaborative quality improvement study is to improve early identification of malnutrition in the post-HSCT patient population with a standardized screeni [...]
2023 | Final project |
2.
Allogeneic hematopoietic cell transplantation (allo HCT) is the only curative therapy for patients with intermediate-2 or high risk myelofibrosis (MF). We sought to exami [...]
2023-07-19 | Abstract |
3.